Health Technology · Pharmaceuticals: Other · NSE: INFLUX · data 2026-10-09

Influx Healthtech Limited

Health check: Strong (9.3/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹270.35

Market cap

₹602 cr

P/E

28.9

P/B

—

ROE

30.0%

ROCE

38.0%

Debt / equity

—

Dividend yield

0.00%

1-year return

58.1%

52-week high

₹315

52-week low

₹166

Operating margin

17.8%

Growth

Revenue (last 12 months)	₹147 cr
Net profit (last 12 months)	₹21 cr
Sales growth, 3 years (yearly)	24.5%
Profit growth, 3 years (yearly)	41.9%

Similar companies

Amrutanjan Health Care Limited (AMRUTANJAN) · Shri Ahimsa Naturals Limited (SHRIAHIMSA) · Lyka Labs Limited (LYKALABS) · Sat Kartar Life Limited (SATKARTAR) · Natural Capsules Limited (NATCAPSUQ)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INFLUX in NSE Scanner →